<p>Drug Safety</p><p>Antipsychotics And Torsadogenic Risk: Signals Emerging From The FDA Adverse Event Reporting System Database</p><p>Elisabetta Poluzzi, Emanuel Raschi, Ariola Koci, Ugo Moretti, Edoardo Spina, Elijah R Behr, Miriam Sturkenboom, Fabrizio De Ponti</p><p>Correspondence: [email protected]</p><p>Electronic Supplementary Material</p><p>1 Table S2. Outcome Codification List of the codes used for the search strategy according to both for MedDRA and WHO-ART terminologies. The analysis of the FDA_AERS requires only MedDRA terminology. The list was finally adopted as of 7-02-2011.</p><p>Group 1 – TORSADE DE POINTES</p><p>MedDRA MedDRA PT WHO-ART WHO-ART PT description (all LLT description (all IT included) included) Torsades de pointes # 10044066 Torsade de pointes 1431</p><p>Group 2 – QT INTERVAL ABNORMALITIES</p><p>MedDRA description MedDRA PT WHO-ART description WHO-ART PT WHO-ART IT (all LLT (all IT included) included) Electrocardiogram QT prolonged # 10014387 QT prolonged 1361 Long QT syndrome # 10024803 ECG QT interval abnormal 0503010</p><p>Long QT syndrome congenital # 10057926 QT syndrome congenital 1165002</p><p>Electrocardiogram QT interval abnormal 10063748 ECG U wave abnormality 0503009</p><p>Electrocardiogram QT shortened 10014388 Electrocardiogram 0503007 repolarisation abnormal Electrocardiogram U-wave abnormality $ 10055032 Electrocardiogram R on T 0503008 phenomenon Electrocardiogram U-wave biphasic $ 10055068 Electrocardiogram repolarization abnormality $ 10052464 Electrocardiogram R on T phenomenon 10048883</p><p>Note that WHO-ART terminology does not distinguish between QT abnormalities and QT shortening.</p><p>2 Group 3 – VENTRICULAR FIBRILLATION/TACHYCARDIA</p><p>3A – Ventricular fibrillation OR Cardiac fibrillation</p><p>MedDRA description MedDRA PT WHO-ART description WHO-ART PT (all LLT included) (all IT included) Ventricular fibrillation $ 10047290 fibrillation ventricular 0440</p><p>Ventricular flutter $ 10047294 fibrillation cardiac 0442 Cardiac fibrillation $ 10061592</p><p>3B and 3C – Ventricular tachycardia OR Ventricular arrhythmia OR tachyarrhythmia</p><p>MedDRA description MedDRA PT MedDRA WHO-ART description WHO-ART PT WHO-ART IT (all LLT included) LLT (all IT included) Ventricular tachicardia # 10047302 Tachycardia ventricular 0230</p><p>Ventricular tachyarrhythmia 10065341 Arrhythmia ventricular 0435 Ventricular arrhythmia $ 10047281 Tachycardia 0224</p><p>Ventricular extrasystoles 10047289 Extrasystoles 0438</p><p>Tachycardia 10043071 Tachyarrhythmia 0433002</p><p>Tachycardia Foetal 10043074</p><p>Tachycardia Paroxysmal 10043079</p><p>Tachyarrhythmia 10049447</p><p>Neonatal tachycardia 10049775</p><p>Extrasystoles 10015856</p><p>3 Group 4 – SUDDEN CARDIAC DEATH</p><p>4A – Sudden cardiac death OR cardiac arrest OR sudden (unexpected) death</p><p>MedDRA description MedDRA PT WHO-ART description WHO-ART PT (all LLT included) (all IT included) Sudden cardiac death $ 10049418 cardiac arrest 0437</p><p>Cardiac arrest $ 10007515 cardiac arrest neonatal 0834</p><p>Cardiac arrest neonatal 10007516 sudden death 1134</p><p>Cardio-respiratory arrest $ 10007617 sudden infant death syndrome 0981</p><p>Cardio-respiratory arrest neonatal 10007618</p><p>Ventricular asystole 10047284</p><p>Sudden death $ 10042434</p><p>Sudden infant death syndrome 10042440</p><p>4B – Syncope</p><p>MedDRA description MedDRA PT WHO-ART description WHO-ART PT (all LLT included) (all IT included) Adams-Stokes syndrome 10001115 Syncope 0223 Syncope $ 10042772</p><p>Drop attacks 10013643 Loss of consciousness $ 10024855</p><p># included in the narrow search strategy of the SMQ “TdP/QT prolongation” $ included in the broad search strategy of the SMQ “TdP/QT prolongation”</p><p>4</p>